Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BOK
|
|||
| Former ID |
DIB015757
|
|||
| Drug Name |
DiabeCell
|
|||
| Synonyms |
Porcine pancreatic islet cell therapy (Immupel encapsulated, type 1 diabetes), LCT; Porcine pancreatic islet celltherapy (alginate encapsulated, type 1 diabetes), LCT
Click to Show/Hide
|
|||
| Indication | Insulin-dependent diabetes [ICD-11: 5A10] | Phase 2 | [1] | |
| Company |
Living Cell Technologies Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | T-cells (T-cells) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01736228) Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus. U.S. National Institutes of Health. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.